It does imply AMPA antagonists or NAMs might be of interest to people with this problem, though
It does not necessarily.
For example, if the increased AMPA density is a counter-regulatory response to reduced baseline AMPA activation, further antagonizing the receptor system would worsen rather than improve the situation.
Comments
It does not necessarily.
For example, if the increased AMPA density is a counter-regulatory response to reduced baseline AMPA activation, further antagonizing the receptor system would worsen rather than improve the situation.
Possible, which is why I said "might be" and brought up that memantine seems to contribute positively to brain fog.